Synergistic activities of gatifloxacin in combination with other antimicrobial agents against Pseudomonas aeruginosa and related species

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 11, 2001, Pages 3220-3222

  Gradelski, E ^a   Valera, L ^a   Bonner, D ^a   Fung Tomc, J ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFEPIME; CEFOPERAZONE; CEFTAZIDIME; CHLORAMPHENICOL; COTRIMOXAZOLE; GATIFLOXACIN; IMIPENEM; MINOCYCLINE; PIPERACILLIN; TIMENTIN;

ACINETOBACTER; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BURKHOLDERIA; CONCENTRATION RESPONSE; DRUG EFFECT; DRUG POTENTIATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STENOTROPHOMONAS;

AMIKACIN; ANTI-BACTERIAL AGENTS; DRUG SYNERGISM; FLUOROQUINOLONES; LACTAMS; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA;

EID: 0034775465     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.11.3220-3222.2001     Document Type: Article

References (17)

1. Activities of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with amikacin, against acinetobacters as determined by checkerboard and time-kill studies
2. Synergy of ciprofloxacin and azlocillin in vitro and in a neuropenic mouse model of infection
3. In vitro activity of aztreonam, cefotaxime, ceftazidime and imipenem combined with ciprofloxacin against Gram-negative bacilli and compared with amikacin combinations against Pseudomonas aeruginosa
4. Antibiotic combinations: Should they be tested?
5. In vitro antibacterial spectrum of a new broad-spectrum 8-methoxy fluoroquinolone, gatifloxacin
6. Comparative killing rates of fluoroquinolones and cell-wall active agents
7. Ciprofloxacin interactions with imipenem and amikacin against multiresistant Pseudomonas aeruginosa
8. Synergism between aminoglycosides and cephalosporins with antipseudomonal activity: Interaction index and killing curve method
9. The choice of antibacterial drugs
10. Evaluation of ciprofloxacin's synergism with other agents by multiple in vitro methods
11. Synergy of fluorqainolones with other antimicrobial agents
12. Synergy and antagonism of combinations with quinolones
13. Activities of three quinolones, alone and in combination with extended-spectrum cephalosporins or gentamicin, against Stenotrophomonas maltophilia
14. Comparative activity, of trovafloxacin, alone and in combination with other agents, against gram-negative nonfermentative rods